Northwest Chapter of the
Huntington's Disease Society of America
Help with Team Hope Walk-a-thons
The Northwest Chapter of the HDSA will be
holding its 3rd Annual Team Hope Walk-a-thon this late
summer/early fall in Washington state in addition to it's 1st
Portland area walk. We could use your help!
We'll need help with registration, set-up, clean-up and other
miscellaneous tasks. If you would like to help, please contact the event
coordinator:
Roxanne Harris
phone: 206.434.9173
email:
info@nwhdsa.org
Participate in Huntington's Disease Research
Currently, three Northwest Huntington's Disease research studies
are looking for participants. Your participation in these types of
studies is critical for finding effective ways to slow down or cure
Huntington's Disease. Please consider participating in one or more
of the below studies.
PHAROS (Prospective HD at Risk Observational Study)
- An observational study to advance knowledge about the experience
of being at risk for HD, and to lay the groundwork for future
studies of treatments to delay onset. The requirements for
volunteers are: 26 - 55 year of age, at risk for HD (an affected
parent) and never had gene testing. Volunteers are evaluated by two
neurologists and a nurse practitioner every nine months. The
University of Washington is enrolling new subjects.
PREDICT - HD (Neurologic Predictors of HD) - An
observational study of the behavioral and MRI predictors of HD
onset. This study differs from PHAROS in having more detailed
testing of concentration and memory in addition to a neurologic
examination and a MRI of the brain. The requirements for volunteers
are: 26 years of age and older, tested for the HD gene (both
negative and positive), never diagnosed with onset of HD by a
physician, and able to bring a companion along to each visit.
Volunteers are evaluated by a movement disorder specialist and a
nurse practitioner every year. The University of Washington is
enrolling new subjects. Subjects are compensated for visits.
Spinal Fluid Biomarkers in HD - A study of spinal
fluid in persons affected with early symptoms of HD and unaffected
persons as controls, to determine whether there are changes in
spinal fluid that will be useful in understanding the biologic
events occurring in the brains of persons with HD. Biomarkers might
be useful in identifying the earliest stages of HD, following the
progression of the disease, or in monitoring the effects of
treatments. The University of Washington is enrolling new subjects.
Subjects are compensated for participation.
If you have questions or are interested in being a volunteer for any
of the above studies, contact Hillary Lipe, ARNP, Study Coordinator,
at (800)329-8387 X61825 or (206)277-1825.